[EN] KCNT1 INHIBITORS AND METHODS OF USE [FR] INHIBITEURS DE KCNT1 ET MÉTHODES D'UTILISATION
摘要:
Disclosed herein are compounds and compositions useful for preventing and/or treating a neurological disorder, a disorder associated with excessive neuronal excitability, or a disorder associated with a gain-of-function mutation in a gene (e.g., KCNT1). Methods of treating a neurological disorder, a disorder associated with excessive neuronal excitability, or disorder associated with a gain-of-function mutation in a gene such as KCNT1 are also provided herein.
[EN] KCNT1 INHIBITORS AND METHODS OF USE<br/>[FR] INHIBITEURS DE KCNT1 ET MÉTHODES D'UTILISATION
申请人:[en]PRAXIS PRECISION MEDICINES, INC.
公开号:WO2022231872A1
公开(公告)日:2022-11-03
Disclosed herein are compounds and compositions useful for preventing and/or treating a neurological disorder, a disorder associated with excessive neuronal excitability, or a disorder associated with a gain-of-function mutation in a gene (e.g., KCNT1). Methods of treating a neurological disorder, a disorder associated with excessive neuronal excitability, or disorder associated with a gain-of-function mutation in a gene such as KCNT1 are also provided herein.
Belzecki,C. et al., Bulletin de l'Academie Polonaise des Sciences, Serie des Sciences Chimiques, 1970, vol. 18, p. 431 - 436